TCI Wealth Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

TCI Wealth Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-303	Closed	-$2.68K	–	2028
2023 Q1	$2.68K	Buy	303 +103	+52%	+$1.02K	﹤0.01%	1895
2022 Q4	$1.82K	Hold	200	–	–	﹤0.01%	1997
2022 Q3	$2K	Hold	200	–	–	﹤0.01%	1995
2022 Q2	$2K	Hold	200	–	–	﹤0.01%	2051
2022 Q1	$2K	Hold	200	–	–	﹤0.01%	2031
2021 Q4	$2K	Hold	200	–	–	﹤0.01%	2126
2021 Q3	$2K	Hold	200	–	–	﹤0.01%	2181
2021 Q2	$2K	Hold	200	–	–	﹤0.01%	2099
2021 Q1	$2K	Hold	200	–	–	﹤0.01%	1903
2020 Q4	$2K	Sell	200 -50	-20%	-$479	﹤0.01%	1276
2020 Q3	$2K	Hold	250	–	–	﹤0.01%	1184
2020 Q2	$3K	Hold	250	–	–	﹤0.01%	967
2020 Q1	$2K	Sell	250 -23	-8%	-$236	﹤0.01%	1097
2019 Q4	$3K	Hold	273	–	–	﹤0.01%	1056
2019 Q3	$2K	Hold	273	–	–	﹤0.01%	1149
2019 Q2	$3K	Hold	273	–	–	﹤0.01%	934
2019 Q1	$4K	Hold	273	–	–	﹤0.01%	870
2018 Q4	$4K	Hold	273	–	–	﹤0.01%	848
2018 Q3	$6K	Hold	273	–	–	﹤0.01%	764
2018 Q2	$7K	Hold	273	–	–	﹤0.01%	713
2018 Q1	$5K	Hold	273	–	–	﹤0.01%	750
2017 Q4	$5K	Sell	273 -304	-53%	-$4.57K	﹤0.01%	800
2017 Q3	$10K	Sell	577 -22	-4%	-$495	﹤0.01%	604
2017 Q2	$20K	Sell	599 -2,001	-77%	-$61.9K	0.01%	465
2017 Q1	$83K	Sell	2,600 -2,000	-43%	-$68.3K	0.04%	236
2016 Q4	$167K	Sell	4,600 -267	-5%	-$10.7K	0.09%	154
2016 Q3	$224K	Buy	4,867 +2,000	+70%	+$104K	0.12%	120
2016 Q2	$144K	Hold	2,867	–	–	0.08%	160
2016 Q1	$153K	Sell	2,867 -43	-1%	-$2.52K	0.08%	154
2015 Q4	$191K	Sell	2,910 -363	-11%	-$22.4K	0.11%	136
2015 Q3	$185K	Sell	3,273 -67	-2%	-$4.34K	0.11%	135
2015 Q2	$197K	Buy	3,340 +195	+6%	+$12K	0.11%	133
2015 Q1	$196K	Sell	3,145 -470	-13%	-$27.3K	0.12%	115
2014 Q4	$208K	Sell	3,615 -1,410	-28%	-$78.6K	0.13%	121
2014 Q3	$270K	Sell	5,025 -1,908	-28%	-$101K	0.17%	99
2014 Q2	$363K	Buy	6,933 +293	+4%	+$15K	0.22%	78
2014 Q1	$351K	Sell	6,640 -111	-2%	-$5.13K	0.23%	79
2013 Q4	$271K	Sell	6,751 -200	-3%	-$7.88K	0.17%	97
2013 Q3	$263K	Buy	6,951 +200	+3%	+$7.8K	0.2%	86
2013 Q2	$265K	Buy	+6,751	New	+$263K	0.2%	80

Other funds holding TEVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

IAM

Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

TCI Wealth Advisors's TEVA Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Teva Pharmaceuticals (TEVA) in Q2 2023, closing a stake of 303 shares — an estimated $2.68K sold.

TCI Wealth Advisors first reported a position in TEVA in Q2 2013 and held it in 40 quarters. The position peaked at $363K in Q2 2014. 428 funds tracked by Wall St. Rank hold TEVA as of Q2 2023.

TCI Wealth Advisors reported no remaining Teva Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
TCI Wealth Advisors sold 303 Teva Pharmaceuticals shares in Q2 2023, an estimated $2.68K.
TCI Wealth Advisors first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 40 quarters.
TCI Wealth Advisors's Teva Pharmaceuticals position peaked at $363K in Q2 2014.
428 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.